Proteasome Inhibitor [EPC] - N0000175604

Pharmacologic Class Information

Pharmacologic Code N0000175604
Pharmacologic Name Proteasome Inhibitor
Pharmacologic Uses
  • proteasome inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Proteasome Inhibitor

The table contains 33 products whose active ingredient are classified under the same pharmacologic class Proteasome Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0143-9098Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0409-1700Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHospira, Inc.ACTIVE
0409-1703Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHospira, Inc.ACTIVE
0409-1704Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHospira, Inc.ACTIVE
0781-3258Bortezomib Non-Proprietary Name: Bortezomib For InjectionInjection, Powder, Lyophilized, For SolutionIntravenousSandoz IncACTIVE
10019-991Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBaxter Healthcare CorporationACTIVE
25021-244Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
43598-426Bortezomib Non-Proprietary Name: BortexomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousDr.reddy's Laboratories, Inc.ACTIVE
43598-865Bortezomib Non-Proprietary Name: BortexomibInjection, Powder, Lyophilized, For SolutionIntravenousDr.reddy's Laboratories IncACTIVE
50742-484Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousIngenus Pharmaceuticals, LlcACTIVE
51817-586Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousPharmascience Inc.ACTIVE
55150-337Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousEugia Us LlcACTIVE
60505-6050Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousApotex CorpACTIVE
63020-049Velcade Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
63020-230Ninlaro Non-Proprietary Name: IxazomibCapsuleOralTakeda Pharmaceuticals America, Inc.ACTIVE
63020-390Ninlaro Non-Proprietary Name: IxazomibCapsuleOralTakeda Pharmaceuticals America, Inc.ACTIVE
63020-400Ninlaro Non-Proprietary Name: IxazomibCapsuleOralTakeda Pharmaceuticals America, Inc.ACTIVE
63323-821Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
67184-0530Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousQilu Pharmaceutical Co., Ltd.ACTIVE
68001-534Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
68001-540Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
68001-541Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
70511-161Bortezomib Non-Proprietary Name: BortezomibInjectionIntravenousMaia Pharmaceuticals, Inc.ACTIVE
70511-162Bortezomib Non-Proprietary Name: BortezomibInjectionIntravenousMaia Pharmaceuticals, Inc.ACTIVE
70710-1411Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousZydus Pharmaceuticals Usa Inc.ACTIVE
70771-1708Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousZydus Lifesciences LimitedACTIVE
71288-118Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousMeitheal Pharmaceuticals Inc.ACTIVE
72205-183Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousNovadoz Pharmaceuticals LlcACTIVE
76075-101Kyprolis Non-Proprietary Name: CarfilzomibInjection, Powder, Lyophilized, For SolutionIntravenousOnyx Pharmaceuticals, Inc.ACTIVE
76075-102Kyprolis Non-Proprietary Name: CarfilzomibInjection, Powder, Lyophilized, For SolutionIntravenousOnyx Pharmaceuticals, Inc.ACTIVE
76075-103Kyprolis Non-Proprietary Name: CarfilzomibInjection, Powder, Lyophilized, For SolutionIntravenousOnyx Pharmaceuticals, Inc.ACTIVE
83090-008Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousSintetica Us LlcACTIVE
83703-532Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBamboo Us Bidco LccACTIVE